How a new research supplier earned $8.48M from organic search in 21 months
A new domain, more than 150 compounds, and a category most publishers won’t touch. Paid channels are restricted, so organic search is one of the few ways in.

The results
Nov 2024 to Jul 2026
- Organic search revenue
- $8.48Min 21 months, from $0 on a new domain
- Monthly organic revenue
- $835Kin July 2026, from $0
- Organic orders
- 2,210in July 2026, from 0
- Non-brand clicks
- 5,571a month, from 565 in Aug 2025+886%
- Average position
- 10.3in July 2026, from 31.2 in Aug 2025
- Share of company revenue
- 15.5%from organic search, Aug 2025 to Jul 2026
Revenue and orders: GA4, organic search. Clicks and position: Google Search Console, web search, impression-weighted; query-level figures leave out the queries Google anonymizes. Checked 28 Sep 2026.
Contents
The client
A research supplier selling peptides and bioregulators to laboratories, university scientists, contract research organizations and international buyers. More than 150 compounds, every batch tested by independent labs, and a certificate of analysis available before anyone orders.
Their buyers are some of the hardest people online to impress. A researcher arrives with a compound name, a purity threshold and a documentation requirement, and leaves the moment a page can’t meet them.
I started in November 2024, on a new domain with no rankings, no authority and no sales. The store took its first order in December.
The problem
Starting from zero in this category is harder than fixing a bad site. Research compounds sit at the strict end of Google’s Your Money or Your Life standards, so thin or unqualified pages are held back by default. Ad platforms restrict the category, which removes the usual shortcut of buying traffic while search matures. And a new domain has no history to lean on.
Most competitors respond by writing vaguely. Vague copy fails the compliance test and the researcher test at the same time.
The first nine months proved the channel could work: $809,913 in organic revenue. But by August 2025, most search traffic still came from people looking for the company by name. Branded searches brought 5,901 clicks that month, against 565 from everything else. The average position was 31, on page four.
The purity data, the independent testing and the certificates were all real. Search couldn’t find any of it.
The strategy
Product pages built as research references
I wrote every product page to the standard a researcher applies: full analytical specifications, molecular identifiers, purity and testing method, and the relevant literature in original wording. Specification tables replaced blocks of prose. The research-use language is identical on every page, so nothing is left open to interpretation. A page that satisfies a scientist tends to satisfy Google.
Publishing at the pace the category rewards
The editorial calendar runs five to ten articles a week, each tied to a compound, a research question and a stage of the buyer’s evaluation. Every article opens with a four-line highlights block that answers the search. Sections stay short and tables carry the detail. Nothing strays outside research use: no dosing and no therapeutic framing. Most competitors treat those limits as a reason to publish nothing.
Certificates that rank
The certificates of analysis were the brand’s strongest proof, and search couldn’t see them. I turned them into indexable pages tied to specific batches and compounds. They now bring in researchers checking a supplier before they order.
The architecture underneath
I structured the categories, built internal links across the catalog and organized the compound taxonomy, so category pages, blends and single compounds support each other instead of competing. In the second year, the number of pages earning impressions roughly doubled.
Reporting on revenue, not rankings
Search Console and GA4 feed one warehouse, so a ranking change can be traced to sessions, orders and revenue. Keyword counts show where things are heading. Revenue shows whether the work paid.
The outcome
Twenty-one months in, organic search has earned $8.48M for a domain that started with nothing. Most of it came in the second year.
| Period | Organic revenue | Monthly average |
|---|---|---|
| Months 1 to 9 | $809,913 Nov 2024 to Jul 2025 | $89,990 |
| Months 10 to 21 | $7,671,685 Aug 2025 to Jul 2026 | $639,307 |
| July 2026 | $835,232 | One month |
Month for month, the second period earned about seven times the first, on the same site with the same team. July 2026 alone earned more than the whole of the first nine months.
Visibility moved first. By July 2026 the site was on page one for 8,499 search queries, and in the top three for 2,760. Between August 2025 and July 2026, the average position went from 31 to 10.
Then the searches that matter most grew. Clicks from people who weren’t looking for the company by name rose from 565 a month to 5,571, almost ten times as many, on about seven times the impressions. That’s demand the brand didn’t have before, caught while a researcher is choosing a supplier.
Then it paid better. Revenue per organic session rose from about $6.30 in the first nine months to about $13.70 in the next twelve, so the traffic grew and got more qualified at the same time. Over those twelve months, organic search earned 15.5% of the company’s revenue. In July 2026 it earned 20.5%.
Branded search more than doubled as well, from 5,901 clicks a month to 13,060. A catalog that turns up for compound searches builds a name people search for later.


